Qtron Investments’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
5,621
-710
-11% -$148K 0.18% 112
2026
Q1
$1.34M Buy
6,331
+3
+0% +$646 0.18% 125
2025
Q4
$1.3M Sell
6,328
-228
-3% -$42.9K 0.17% 126
2025
Q3
$1.03M Sell
6,556
-1,357
-17% -$210K 0.13% 190
2025
Q2
$1.33M Hold
7,913
0.17% 142
2025
Q1
$1.09M Buy
7,913
+572
+8% +$72.9K 0.16% 161
2024
Q4
$868K Hold
7,341
0.12% 207
2024
Q3
$811K Hold
7,341
0.11% 248
2024
Q2
$722K Hold
7,341
0.1% 231
2024
Q1
$821K Hold
7,341
0.12% 227
2023
Q4
$740K Sell
7,341
-804
-10% -$79.8K 0.12% 223
2023
Q3
$707K Buy
8,145
+2,843
+54% +$257K 0.13% 218
2023
Q2
$501K Buy
5,302
+2,242
+73% +$189K 0.1% 277
2023
Q1
$231K Hold
3,060
0.05% 378
2022
Q4
$235K Buy
+3,060
New +$233K 0.05% 386

Other funds holding CAH

Qtron Investments's CAH Position: Q2 2026 in Review

Qtron Investments reduced its Cardinal Health (CAH) stake by 11% in Q2 2026, selling an estimated $148K and leaving 5,621 shares worth $1.34M. The position accounts for 0.18% of the portfolio, ranked #112.

Qtron Investments first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.34M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Qtron Investments held 5,621 shares of Cardinal Health worth $1.34M as of Q2 2026.
  • Qtron Investments sold 710 Cardinal Health shares in Q2 2026, an estimated $148K.
  • Cardinal Health made up 0.18% of Qtron Investments's portfolio in Q2 2026, its #112 holding.
  • Qtron Investments first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • Qtron Investments's Cardinal Health position peaked at $1.34M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.